Abstract
A 78-year-old man with prostate cancer was referred for 18F-NaF PET/CT for assessing bone metastases. An 18F-NaF PET/CT study was performed after the intravenous administration of the radiopharmaceutical. Five days later, a second study was done after oral administration of the radiopharmaceutical as part of a research protocol.
Publication types
-
Case Reports
-
Comparative Study
MeSH terms
-
Administration, Intravenous
-
Administration, Oral
-
Aged
-
Bone Neoplasms / diagnostic imaging*
-
Bone Neoplasms / secondary
-
Fluorides / administration & dosage*
-
Humans
-
Male
-
Multimodal Imaging
-
Phosphates / administration & dosage*
-
Positron-Emission Tomography
-
Prostatic Neoplasms / diagnostic imaging*
-
Prostatic Neoplasms / pathology
-
Radiopharmaceuticals / administration & dosage*
-
Tomography, X-Ray Computed
Substances
-
Phosphates
-
Radiopharmaceuticals
-
fluorophosphate
-
Fluorides